Globally, the Johnson & Johnson vaccine is expected to play an important role, especially in low and middle-income countries, because it works after just one shot, is relatively inexpensive, and is easier to store and distribute than the vaccines made by Pfizer-BioNTech and Moderna.from Industry-Economic Times
Read The Rest:economictimes...
